HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 4.5 CAD
Market Cap: CA$140.7m

Relative Value

The Relative Value of one HLS stock under the Base Case scenario is 5.48 CAD. Compared to the current market price of 4.5 CAD, HLS Therapeutics Inc is Undervalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HLS Relative Value
Base Case
5.48 CAD
Undervaluation 18%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

HLS Competitors Multiples
HLS Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
HLS Therapeutics Inc
TSX:HLS
140.7m CAD 1.8 -7.3 8.9 -24.2
US
Mckesson Corp
NYSE:MCK
119.4B USD 0.3 29.6 20.8 23.4
US
Cencora Inc
NYSE:COR
70.7B USD 0.2 45.3 15.3 19.7
US
Amerisourcebergen Corp
LSE:0HF3
70.5B USD 0.2 45.4 15.3 19.7
US
Cardinal Health Inc
NYSE:CAH
53.4B USD 0.2 32.1 15.4 20
AU
Sigma Healthcare Ltd
ASX:SIG
35.5B AUD 5.9 67 50.5 50.5
US
Henry Schein Inc
NASDAQ:HSIC
9.5B USD 0.7 24.4 11.6 16.2
CN
Huadong Medicine Co Ltd
SZSE:000963
64.2B CNY 1.5 17.4 13.4 13.4
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.1B CNY 0.2 11.4 15.2 15.2
CN
Sinopharm Group Co Ltd
HKEX:1099
66.2B HKD 0.1 8.6 1.6 2
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9